IP Library Patent Application 11473515
Patent Application
App. No. 11/473,515

Iontophoresis device controlling administration amount and administration period of plurality of drugs

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/473,515
Abstract

An iontophoresis device capable of administering a plurality of drugs to a living body while controlling the administration amounts and the administration periods thereof is described. The iontophoresis device may comprise: a power source device; a drug administration unit connected to the power source device and including at least two electrode structures that hold an ionic drug; and a current control unit that individually controls currents flowing to the electrode structures. A predetermined amount of the ionic drug may be released from each of the electrode structures to be administered transdermally to a living body in a predetermined period of time according to a current flowing from the current control unit.

Claims (50)

1 . An iontophoresis device comprising:

a power source device;

a drug administration unit coupled to the power source device and comprising at least a first electrode structure and a second electrode structure that each hold an ionic drug; and

a current control unit that individually controls currents flowing to the first and the second electrode structures,

wherein a predetermined amount of the ionic drug is released from each of the first and the second electrode structures to be administered transdermally to a living body in a predetermined period of time according to a current flowing from the current control unit.

2 . An iontophoresis device according to claim 1 , wherein the drug administration unit further comprises at least a third electrode structure that does not hold an ionic drug as a counter electrode to the first and the second electrode structures.

3 . An iontophoresis device according to claim 2 , wherein:

the first electrode structure comprises:

an electrode having the same polarity as that of a drug component of the ionic drug in the electrode structure, the electrode being connected to the power source device;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode;

an ion exchange membrane that selectively passes ions having a polarity opposite to that of a charged ion of the ionic drug, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion;

a drug holding portion impregnated with the ionic drug, the drug holding portion being placed adjacent to the ion exchange membrane; and

an ion exchange membrane that selectively passes ions having the same polarity as that of a charged ion of the ionic drug, the ion exchange membrane being placed adjacent to the drug holding portion; and

the third electrode structure comprises:

an electrode having a polarity opposite to that of the electrode of the first electrode structure;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode; and

an ion exchange membrane that selectively passes ions having a polarity opposite to that of a charged ion of the ionic drug in the first electrode structure, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion.

4 . An iontophoresis device according to claim 2 , wherein:

the first electrode structure comprises:

an electrode having the same polarity as that of a drug component of the ionic drug in the electrode structure, the electrode being connected to the power source device;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode;

an ion exchange membrane that selectively passes ions having a polarity opposite to that of a charged ion of the ionic drug, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion;

a drug holding portion impregnated with the ionic drug, the drug holding portion being placed adjacent to the ion exchange membrane; and

an ion exchange membrane that selectively passes ions having the same polarity as that of a charged ion of the ionic drug, the ion exchange membrane being placed adjacent to the drug holding portion; and wherein

the third electrode structure comprises:

an electrode having a polarity opposite to that of the electrode in the first electrode structure;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode;

an ion exchange membrane that selectively passes ions having the same polarity as that of a charged ion of the ionic drug in the first electrode structure, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the ion exchange membrane; and

an ion exchange membrane that selectively passes ions having a polarity opposite to that of a charged ion of the ionic drug in the first electrode structure, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion.

5 . An iontophoresis device according to claim 2 , wherein:

the first electrode structure comprises:

an electrode having the same polarity as that of a drug component of the ionic drug in the electrode structure, the electrode being connected to the power source device;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode;

an ion exchange membrane that selectively passes ions having a polarity opposite to that of a charged ion of the ionic drug in the first electrode structure, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion;

a drug holding portion impregnated with the ionic drug, the drug holding portion being placed adjacent to the ion exchange membrane; and

an ion exchange membrane that selectively passes ions having the same polarity as that of a charged ion of the ionic drug in the first electrode structure, the ion exchange membrane being placed adjacent to the drug holding portion; and

the third electrode structure comprises:

an electrode having a polarity opposite to that of the electrode of the first electrode structure;

an electrolyte solution holding portion impregnated with an electrolyte solution, the electrolyte solution holding portion being placed adjacent to the electrode;

an ion exchange membrane that selectively passes ions having a polarity opposite to that of a charged ion of the ionic drug in the second electrode structure, the ion exchange membrane being placed adjacent to the electrolyte solution holding portion;

a drug holding portion impregnated with an ionic drug, the drug holding portion being placed adjacent to the ion exchange membrane; and

an ion exchange membrane that selectively passes ions having the same polarity as that of a charged ion of the ionic drug in the second electrode structure, the ion exchange membrane being placed adjacent to the drug holding portion.

6 . An iontophoresis device according to claim 1 , wherein the drug administration unit is configured integrally.

7 . An iontophoresis device according to claim 1 , wherein the current control unit comprises a load resistor provided between the electrode structure and the power source device, a current detecting portion that detects a current flowing to the load resistor, and a feedback control portion that allows a controlled current to flow to the electrode structure.

8 . A method of operating the iontophoresis comprising a power source device, a drug administration unit coupled to the power source device and comprising at least a first and a second electrode structure that each hold an ionic drug, and a control unit that individually controls a current flow to each of the electrode structures, the method comprising:

placing the drug administration unit on a skin surface of a living body;

passing a current through the drug administration unit from the power source device;

individually controlling currents flowing to the electrode structures with the current control unit; and

releasing a predetermined amount of the ionic drug from each of the electrode structures in a predetermined period of time.

Assignments (5)
RESCISSION OF PRIOR ASSIGNMENT Recorded Mar 10, 2008
From: TRANSCU LTD.
To: TTI ELLEBEAU, INC.
Reel/Frame 020626/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2007
From: TTI ELLEBEAU, INC.
To: TRANSCU LTD.
Reel/Frame 020236/0175 →
CHANGE OF NAME Recorded Dec 7, 2007
From: ELLEBEAU, INC.
To: TTI ELLEBEAU, INC.
Reel/Frame 020214/0336 →
MERGER Recorded Dec 5, 2007
From: TRANSCUTANEOUS TECHNOLOGIES, INC.
To: ELLEBEAU, INC.
Reel/Frame 020200/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2006
From: MATSUMURA, AKIHIKO; MATSUMURA, TAKEHIKO; NAKAYAMA, MIZUO; AKIYAMA, HIDERO; SHIBATA, TSUTOMU
To: TRANSCUTANEOUS TECHNOLOGIES INC.
Reel/Frame 018188/0229 →